Page last updated: 2024-11-07

aethiopinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

aethiopinone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID157301
MeSH IDM0267168

Synonyms (4)

Synonym
aethiopinone
1,2-naphthalenedione, 7-methyl-3-(1-methylethyl)-8-(4-methyl-4-pentenyl)-
79491-58-0
DTXSID00229714

Research Excerpts

Overview

Aethiopinone is an in vitro inhibitor of 5-LO from human neutrophils (IC50 = 0.11 microM)

ExcerptReferenceRelevance
"Aethiopinone is an in vitro inhibitor of 5-LO from human neutrophils (IC50 = 0.11 microM)."( Inhibition of 5-lipoxygenase activity by the natural anti-inflammatory compound aethiopinone.
Alcaraz, MJ; Benrezzouk, R; Ferrandiz, ML; Hernandez-Perez, M; Rabanal, R; Terencio, MC, 2001
)
1.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]